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Hematologic cancers, broadly categorized as leukemias, lymphomas, and myelomas, are 
diagnosed in 3.3 million people globally, and account for 10% of new cancer cases in the U.S. 
every year. In the last decade, newer treatments that directly target aberrant molecular processes, 
rather than the entire cell, have provided a less toxic alternative to traditional chemotherapy, 
however, identification of targets for molecular inhibitors is a major rate-limiting step. Recent 
studies have demonstrated the efficacy of utilizing Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPR) as a mechanism to conduct forward genetic screens and combining 
the results with existing drugs to significantly improve identification of probable therapeutics.  
The following study explores an algorithm to process data from pooled CRISPR forward 
genetic screens to rapidly prioritize potential targets. Currently, targets of interest are manually 
curated by comparing pooled CRISPR data to existing gene, protein, and drug databases. This is a 
Sisyphean task as individual gene products vary among individuals, while gene pathway products 
are consistently similar. Thus, our algorithm will rapidly aggregate genes of interest for a pre-
determined synergistic value (p-value, false discovery rate (FDR-value)), while simultaneously 
performing an efficient gene pathway level analysis by automatically comparing against known 
databases including pathway analysis, drug/protein interaction databases, and biomedical 
literature. The algorithm will quickly display the common gene pathways, the genes involved in 
respective pathways, their synergistic values in a prioritized fashion, and will include database 
results in an easy-to-read table to focus on potential targets for future research. The significantly 
reduced human labor in data processing due to the development of this algorithm will be critical 
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Hematologic cancers are broadly categorized as cancers that begin in blood-forming tissue 
such as the bone marrow, or in the cells of the immune system and are classified into three types: 
leukemias, lymphomas, and myelomas. Leukemia is identified by an uncharacteristically high 
production of leukocytes, a type of white blood cells, which suppresses the function of normal 
blood cells leading to anemia and other symptoms. Lymphoma is found primarily within the lymph 
nodes; these nodes are part of the lymphatic network that allow free movement of the immune 
system. Myeloma is defined by cancerous plasma cells, a variant of white blood cell, found within 
the bone marrow. After identification, the prognosis varies for every individual, however, these 
cancers are diagnosed in 3.3 million individuals, and account for 10% of all new cancer cases in 
the United States every year1. The prevalence of this disease does not guarantee a solution, or a 
cure. Most cancer treatment therapies are expensive and non-curative. As recently as 2014, the 
average yearly cost of orally administered cancer drugs was $135,0002, and in 2017, a potential 
treatment to cure childhood leukemia cost $475,000 per patient2. The cost of cancer therapies has 
been monitored for a decade, and the continuous but steady rise is approaching an unprecedented 
precipice primarily due to targeted therapies supplanting traditional chemotherapeutics.  
1.1 Therapeutics 
Traditional chemotherapy was novel in mitigating the growth of cancer, but it is inherently 
flawed as it lacks specificity. This broad-spectrum approach creates a toxic environment within 
the body which limits proliferation of cancerous tissue, but causes numerous side effects such as 
hair loss, nausea, and weakness which have been extensively studied. To counteract the negative 




Targeted therapies are the foundation of precision medicine as the treatment regime is 
focused to interfere with specific molecules, and molecular processes3 within cancer cells. The 
highly localized treatment ensures fewer side effects for the patient, however, physicians are 
limited in their selection of therapies, some of which include introducing monoclonal antibodies3, 
targeting small molecule inhibitors3, or targeting nuclear export inhibitors4. The identification of 
newer therapies is a major rate-limiting step; fortunately, the technological marvel of Clustered 
Regularly Interspaced Short Palindromic Repeats (CRISPR) can improve the identification of 
molecular targets advancing research on synthetic lethality, i.e. synergy, which arises through the 
cooperative effects of gene knockout and targeted drug delivery5–7. 
1.2 Identifying targets 
CRISPR is the next step in advancing precision medicine for cancer treatment8. The rapid 
gene knockdown ability of CRISPR is unparalleled in specificity and allows deeper insight in 
identifying genes responsible for a particular phenotype of the organism9. The application of 
forward genetic screen is useful in predicting synthetic lethality10, and is fundamentally different 
from reverse genetic screens where the phenotype of the organism is analyzed after the disruption 
of a known gene.  
 
Figure 1: CRISPR knockout screen design. In this example midostaurin, a known chemotherapeutic, is used to 




The current process of identifying a lethal target is labor and time intensive with the 
following example building on the work conducted by our research lab in identifying XPO1 as a 
lethal target4. A cell culture must be infected with a virus containing genome-wide sgRNA library. 
The target result is a 1:1 ratio with one gene knocked down in every cell. In theory, this would 
create a cell culture where one gene is absent in every cell throughout the genome. Now, a simple 
drug is injected to screen-out any cells that did not get infected by the virus. The experiment then 
continues by splitting the cell culture into a control, and a drug condition. Both of these 
experiments yield significant results as shown in Figure 1. The DMSO, control condition, reveals 
which gene knockdowns are vital for survival, while the midostaurin, drug condition, reveals two 
results: which gene knockdown confers resistance to the drug for the proliferating cells, i.e. 
positively select for survival, and which gene knockdown confers synthetic lethality to the non-
proliferating cells, i.e. negatively select for survival. The data from this experiment is vast and 
compiled into Figure 2 for better representation. This large dataset is then manually parsed to 
 
Figure 2: A Volcano Plot aggregating the results from the CRISPR knockout screen (Figure 1). Here, the 
significant positive and negative selection results are organized by their false discovery rate (FDR) and plotted on 




identify genes with existing inhibitors, and the chosen targets are chosen for further 
experimentation to ensure consistency and significance of results.  
While the utilization of CRISPR in screening for drug target discovery11 is evident, it is a 
Sisyphean task to manually parse individual gene products as they could vary among individuals. 
It is much more important to compare gene pathway products as they are consistently similar 
among individuals in the same species. A sample gene pathway analysis is shown as Figure 3, and 
it is important to note the lack of prioritization of genetic pathways (y-axis), or the genes 
themselves (x-axis). This lack of prioritization places greater burden on the scientist and increases 
the time required to identify a viable therapeutic.   
1.3 Goal 
As Figure 3 demonstrates a snippet of all the data aggregated for one drug condition, when 
research is conducted for multiple drug conditions, the gene pathway analysis results increase, and 
manually parsing the data becomes unfeasible. As such, it is important to construct a versatile 
algorithm to parse large datasets to find similarities among gene pathway analyses. These results 
must be prioritized to guide and improve research into synthetically lethal conditions using existing 
drugs, to mitigate cancer, and advance patient therapeutics.   
 
 
Figure 3: Enriched gene pathway analysis of the CRISPR knockout screen4 (Figure 1). The pathways are on the 
y-axis, while individual genes are on the x-axis. The color of the dot represents he significance of the gene in the 





 In an effort to automate data analysis from the massive multiplex CRISPR screens, a 
MATLAB-based algorithm was constructed. The primary objective of the algorithm is to parse 
through the multiple gene pathway level analyses to identify common gene pathways and prioritize 
the results with respect to the false discovery rate (FDR). The FDR value is the expected proportion 
of type I errors, which succinctly indicates the probability of identifying a false positive. As such, 
a small FDR value would be better than a large FDR value, as the smaller FDR value would 
indicate a lower probability of identifying a false positive whereas the larger FDR value would 
indicate a higher probability of identifying a false positive. Thus, by prioritizing the output of the 
algorithm with respect to the FDR-value of the gene pathways and organizing the results in an 
efficient format would ensure the scientist is adequately prepared to continue their investigations.  
2.1 Algorithm Pseudocode 
Take user input for genetic pathway data of both conditions 
Take user input for statistical genetic pathway threshold value  
Loop through each row in genetic pathway data set 
 Loop through each row in the other genetic pathway data set 
  If row1.pathway = row2.pathway 
   Store pathway, statistical values, and gene number ids 
  End if 
 End loop 
End loop 
Loop through stored rows 
 If either statistical value in row more than statistical threshold value 
  Delete row 





Take user input for data of number-to-name of both conditions 
Loop through stored rows 
 Loop through number-to-name data of condition 1 
  If row.gene_number_id_1 = number-to-name.gene_number_id 
   Replace row.gene_number_id_1 with number-to-name.gene_name 
  End if 
 End loop 
 Loop through number-to-name data of condition 2 
  If row.gene_number_id_2 = number-to-name.gene_number_id 
   Replace row.gene_number_id_2 with number-to-name.gene_name 
  End if 
 End loop 
End loop  
Take user input for CRISPR-screened-gene data of both conditions 
Take user input for statistical gene threshold value  
Loop through stored rows 
 Loop through CRISPR-screened-gene data set of condition 1 
  If row.gene_name_1 = CRISPR-screened-gene.gene_name 
   Add CRISPR-screened-gene.statistical_value to stored row 
  End if 
 End loop 
Loop through CRISPR-screened-gene data set of condition 2 
  If row.gene_name_2 = CRISPR-screened-gene.gene_name 
   Add CRISPR-screened-gene.statistical_value to stored row 
  End if 
 End loop 
End loop 




 If gene statistical value in stored rows more than gene threshold value 
  Delete gene and respective gene statistical value 
 End if 
End loop 
Output stored rows as Excel Spreadsheet 
2.2 Capabilities & User Interface 
The MATLAB based algorithm is constructed in a modular format allowing for easy 
application and potential expansion. The user-friendly interface is supportive in guiding the user 
in determining the files necessary to operate the program. Additionally, there is inherent robustness 
integrated within the algorithm to ensure an output is always delivered. This simple capability is 
beneficial in determining the thresholding level and performing effective troubleshooting.  
In the current version, the algorithm requires eight inputs which are summarized in Table 
1. Two files from the CRISPR screen (Figure 4), and two files from the DAVID pathway analysis 
tool are mandatory to use the program. Following these required inputs, the algorithm asks for 
numeric values to threshold the significant results. The user can choose different values of 
 
Figure 4: The sample results from a massive multiplex CRISPR screen are shown in a text file format. The 
important columns include: “target” which refers to genes that exhibit negative-selection, and “FDR” (false 
discovery rate) which refers to a p-value score that is adjusted for Type I errors. 
 
Figure 5: A sample representation of the Non-Extended output format. The genetic pathways and individual genes 
are prioritized by their FDR-values, however, only the FDR-value of the genetic pathway is displayed. 





thresholding for the pathways, and the genes. Finally, the user chooses the name of their output 
Excel spreadsheet, and their preferred formatting condition. The two conditions, extended and 
non-extended, change the amount of information displayed as the output. Both conditions 
prioritize the algorithm output based on the FDR-values but have slightly different benefits. The 
non-extended format is useful for quickly parsing output, while the extended format is beneficial 
in determining the next course of experimentation. Figure 5 and Figure 6 are examples of non-
extended and extended output documents, respectively.  
After ensuring valid inputs, the algorithm rapidly compares the DAVID pathway analysis 
files to determine overlapping pathways. The DAVID Bioinformatics Resource12,13 provides a 
comprehensive set of functional annotation tools to identify enriched biological themes, discover 
enriched functional-related gene groups, and perform greater analysis of enriched pathways on 
large sets of genes. This tool is an open resource to obtain greater knowledge about enriched gene 
pathways, and it utilizes the CRISPR gene list to identify gene pathways and places the genes into 
their respective pathways. As such, when the algorithm parses the DAVID files for similarities, 
the pathway and corresponding genes within the pathways are extracted. Now, the results are 
prioritized with gene pathways and genes organized in ascending order with respect to their FDR-
values. If the user indicated a threshold, it is applied at this step and if the threshold is too stringent, 
 
Figure 6: A sample representation of the Extended output format. The genetic pathways and individual genes are 
prioritized by their FDR-values. Additionally, cell D9 represents the condition when the thresholding value was 




the algorithm writes “No CRISPR screened Genes available at this threshold”. After performing 
the thresholding, the truncated results are shown in the desired output format.  
 
Table 1: Algorithm Inputs 
Name Type Description 
CRISPR Gene List (x2) File type - .txt 
This file is the result of the multiplex 
CRISPR screen; must contain “target”, 
“FDR” values. 
DAVID Pathway analysis (x2) File type - .txt 
This file contains the Pathway Analysis 
results from DAVID. It must contain “GO-
Terms”, “FDR” values, and “Numeric IDs” 
for genes. 
Renamed-Gene IDs (x2) File type - .txt  
 This file contains the conversion of Gene 
IDs to Entrez-format Number IDs. It must 
contain “To” and “From” columns.  
Pathway analysis threshold Numeric - 0 to 1 
Every pathway from DAVID has an FDR 
score which allows the user to compare 
significance.  
Gene analysis threshold Numeric - 0 to 1 
Every gene from the CRISPR screen has an 
FDR score which allows the user to 
compare significance. 
Output format type Numeric - 0 or 1 
Determines format of Excel spreadsheet. 0 
corresponds to non-extended format, while 
1 corresponds to extended format. 
Output document name String 






3 Results & Verification 
 A tool that is capable of rapid prioritization of potential targets after analyzing multiple 
genetic pathways is presented through this work. Prior to this tool, the multiplex CRISPR screen 
results from Figure 2 were succinctly created into Figure 3, a pathway analysis diagram, through 
a laborious and an extensively manual process of comparing genes to known databases. Now, the 
algorithm can quickly eliminate erroneous genes (i.e. genes that do not qualify within the selected 
FDR-threshold value) by effectively, and efficiently parsing through the multiplex CRISPR screen 
data. The algorithm is also capable of comparing multiple genetic pathway analyses and 
prioritizing the common pathways in an easy-to-read Excel spreadsheet to holistically inform the 
scientist on the best potential targets to researcher further. Additionally this rapid pathway-level 
analysis will yield a greater number of potential targets for synthetic lethality, allowing scientists 
to focus their experiments to discover novel therapeutics and enhance precision medicine by 
targeting genetic pathways to improve patient outcomes.  
 The current version of the algorithm has also been verified to ensure results are consistent. 
The code was initially verified by comparing the number of overlapping pathways identified by 
the algorithm with the manual approach. The results demonstrated that the algorithm was able to 
identify a greater number of overlapping pathways much quicker, and further inspection revealed 
novel pathways previously missed by the manual approach. After this success, the algorithm 
performed an analysis of an experiment where a cell line infected with leukemia was treated with 
two drugs and was analyzed by a multiplex CRISPR screen. The algorithm identified a significant 
genetic pathway in “mRNA splicing via spliceosome”. This unique result was recently published 




verification sheds light on the direct impact of this tool, and its efficacy in aiding scientists to 
develop unique therapies and improve patient outcomes.  
4 Future Research 
The algorithm is a powerful tool demonstrating an easy-to-use functionality, and a 
comprehensive output capability through an Excel spreadsheet prioritizing results from a massive 
multiplex CRISPR screen. This tool has already impacted the decision-making of scientists within 
the Experimental Hematology Research Lab, however, there are still avenues for improvement.  
4.1 DAVID API 
The current version of the algorithm relies on the online version of the DAVID 
Bioinformatics Resource12,13 to perform the genetic pathway analysis for each massive multiplex 
CRISPR gene list. While this online resource is useful, it is time-consuming and error-prone to 
copy-paste the numerous gene lists into DAVID and save the output files in the specified format. 
In a future iteration, it will be beneficial to either download and locally host the DAVID 
Knowledgebase or utilize the DAVID API script files to link the algorithm to the DAVID 
Knowledgebase. It would be preferred to locally host the knowledgebase as it provides unlimited 
access to the entire database, whereas the API is restricted to a certain number of interactions. 
Additionally, as the entire database is clustered and centralized by a single index DAVID Gene 
identifier, locally hosting the database will enable the algorithm to perform extremely efficient and 
rapid data processing. The algorithm can be streamlined to require only CRISPR gene lists which 
would tremendously assist the scientist as the pathway analysis, and prioritization of potential 





4.2 Screen-out Essential Gene 
Essential genes are indispensable genes critical for an organism to grow and survive in a 
given environment. In some instances, targeting essential genes could be important for discovering 
novel treatments, while on the contrary excluding essential genes could give insight on 
determining novel cancer-specific gene targets. Currently, the results from the multiplex CRISPR 
screen (i.e. a gene list) are passed through the DAVID database to perform a comprehensive 
pathway-level analysis, as every pathway contains a minimum of one gene from the CRISPR 
screen. The current algorithm does not parse-out essential genes, and to improve the focus on 
cancer-specific targets, several database connections can be incorporated. The Database of 
Essential Genes (DEG)15, and the Online Gene Essentiality database (OGEE)16 are two databases 
which have previously been utilized to screen-out human essential genes. These databases have a 
script file that can be used to connect the algorithm to the online database which would drastically 
improve functionality of the algorithm. After incorporation, the algorithm should feature a toggle 
option to allow the scientist to choose whether to parse-out the essential genes.  
4.3 Database Connections 
The National Center for Biotechnology Information (NCBI) supported by the National 
Institutes of Health is a valuable resource as it hosts databases such as PubMed, PubChem, and 
Gene to Protein, which have established script files making them ideal candidates when expanding 
the algorithm. Every gene from the multiplex CRISPR screen can be passed sequentially through 
the databases to acquire significant information to inform the prioritization of the algorithm. For 
instance, a connection with PubMed will enable existing literature to be identified and curated with 
a focus on specific keywords and the gene of interest. Similarly, a connection with Gene to Protein 




This specific protein information can also guide a future literature search and provide critical 
information on protein-level inhibitors. Finally, a connection with PubChem will enable a greater 
understanding of gene-level molecular inhibitors currently available as well as inhibitors currently 
in research. Beyond the inhibitors found on PubChem, the algorithm can also be connected to the 
short interfering RNA (siRNA) mod database17 to identify non-drug inhibitors, as siRNA are a 
class of non-coding RNA molecules that interfere with gene expression. All of these curated results 
can be displayed as part of the extended-output format, and every result from the databases will be 
incorporated in calculating the new prioritization score to guide the scientist in performing novel 
research.  
4.4 Prioritization Score 
The improved prioritization score would follow an entirely novel format. In the current 
algorithm, pathways, and genes, are prioritized in ascending order based on the false discovery 
rate (FDR) value. As such, pathways, and genes, with a significance close to 0 are ranked higher 
on the output Excel spreadsheet. In the new and improved algorithm, prior to performing any 
comparisons, every gene from the multiplex CRISPR screen will be assigned a prioritization score 
as computed by Eq 1 below, and every pathway from the DAVID analysis will also be assigned a 
prioritization score as computed by Eq 2 below. Additionally, every result from the database (i.e. 
PubMed, PubChem, Gene to Protein, and siRNA mod) will be given a prioritization score of one. 
The database results have a non-changing score of one because existing literature could be sparse 
for certain genes and a score of one would prevent the database results from overweighing the 
prioritization score for a certain pathway. All of these prioritization scores can then be added and 
a threshold can be set to allow for greater specificity of results. Finally, a percentage-based scoring 




components (i.e. gene score, pathway score, and database score). In theory, a scientist can use the 
prioritization score percentage breakdown to identify if the gene of interest has significance, if the 
pathway of interest has significance, and determine if there is existing literature on the 
gene/pathway of interest. The prioritization score will aid the scientist in pursuing novel genes and 
ascertain improved therapeutics for patients.  
Eq 1. Gene Score = 1 −
FDR of individual pathway
highest value of FDR in pathway list
  
Eq 2. Pathway Score = 100 −
FDR of individual pathway
highest value of FDR in pathway list
  
   
5 Conclusion 
 The time undertaken to successfully identify a potential target for synthetic lethality adds 
to the rising cost of novel targeted therapies. The laborious and extensive task of comparing gene 
lists manually is simplified and automated by the algorithm. Although additional functionalities 
can improve this tool as mentioned in the prior sections, however, it is important to note that this 
algorithm still lays the foundation by rapidly comparing genetic pathways, eliminating erroneous 
genes, highlighting a greater number of potential gene targets for synthetic lethality, and 
prioritizing the results in an easy-to-use Excel spreadsheet. The verified algorithm will reduce data 
processing time allowing scientists to focus on significantly important synthetically lethal targets 
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7.1 Gene Pathway Analysis Code 
%% Gene Pathway Analysis Code 
% Author: Mukul Govande 
% Acknowledgement: Andrew Lubinger.1 for assisting in very 
early development 
% Last modified: 03/28/2021 
  
% This program takes in multiple pathway analyses, and 
negative-selected 
% genes from a massive multiplex CRISPR screen, and 
provides a 
% prioritization scheme to inform the user on the best path 
forward. 
%  
% Inputs:  
%       2x CRISPR Gene lists 
%       2x Renamed GENE IDs (this is an output of DAVID 
pathway analysis) 
%       2x DAVID pathway analysis of gene lists 
%       Threshold value for CRISPR Gene list 
%       Threshold value for DAVID pathway analysis 
%       Output Format type (extended vs. non-extended) 
%               
% Outputs:  
%       Excel Data file with prioritized pathways and genes 
  
% Functions used in this script file: 







% Make sure the data files are present in the same folder 
as the MATLAB files. 
% If the data files are not in the same folder, copy the 
entire pathway as 
% the input when prompted to enter the file name in the 





% You will need 2 files from your massive multiplex CRISPR 
screen, 2 files 
% from the DAVID pathway analysis, 2 files from the 
renamed-gene IDs. Please 
% ensure the files from CRISPR has "targets","fdr-values" 
as column 
% headers; ensure the files from DAVID has "go-terms","fdr-
values" as 
% column headers; ensure the files from RENAMED_GENES has 
"FROM","TO" as 
% column headers.  
 
% MAKE SURE ALL DATA FILES ARE IN TEXT FORMAT (i.e. they 
have the .txt 
% extension)  
  




% RENAMED Gene IDs: DAVID is a bioinformatics tool. 
Currently, it is not 
% integrated into this program. So refer to the online 
% website, "david.ncifcrf.gov/home.jsp", copy the CRISPR 
gene list and 
% convert to ENTREZ-GENE-IDs. Store the result as this is 
your renamed-gene 
% IDs. This list will enable conversion from number-IDs to 
name-IDs. 
  
% DAVID Pathway Analysis: Proceed with pathway analysis of 
the converted 
% list. The output is a massive txt file containing GO-
Terms. This is the 
% file used for pathway analysis. 
  
%% Ask for inputs 
  
%prompts 
prompt_c1 = 'Please write the first CRISPR file pathway (or 
file name, include extension!): \n'; 
prompt_c2 = 'Please write the second CRISPR file pathway 




prompt_rn1 = 'Please write the first renamed-gene-number ID 
file pathway (or file name, include extension!): \n'; 
prompt_rn2 = 'Please write the second renamed-gene-number 
ID file pathway (or file name, include extension!): \n'; 
prompt_d1 = 'Please write the first DAVID file pathway (or 
file name, include extension!): \n'; 
prompt_d2 = 'Please write the second DAVID file pathway (or 
file name, include extension!): \n'; 
prompt_th_c = 'Determine the threshold for DAVID pathway 
analysis (numeric): \n'; 
prompt_th_d = 'Determine the threshold for CRISPR analysis 
(numeric): \n'; 
prompt_output = 'Which output format is preferred? 
(extended = 1, non-extended = 0): \n'; 
  
%everything related to condition 1 
crisp_1 = input(prompt_c1,'s'); 
david_1 = input(prompt_d1,'s'); 
rename_1 = input(prompt_rn1,'s'); 
  
%everything related to condition 2 
crisp_2 = input(prompt_c2,'s'); 
david_2 = input(prompt_d2,'s'); 
rename_2 = input(prompt_rn2,'s'); 
  
%threshold values 
threshold_c = input(prompt_th_c); 
%make sure the values are between 0 and 1 
while(threshold_c <= 0 || threshold_c >= 1) 
    disp('ERROR. Please pick a value between 0 and 1.'); 
    threshold_c = input(prompt_th_c); 
end 
  
threshold_d = input(prompt_th_d); 
%make sure the values are between 0 and 1 
while(threshold_d <= 0 || threshold_d >= 1) 
    disp('ERROR. Please pick a value between 0 and 1.'); 




output_type = input(prompt_output); 





    if(output_type == 0) 
    break; 
    elseif(output_type == 1) 
    break; 
    else %i.e. it is not 1 or 0 
        disp('ERROR. Please pick a value of 0 or 1.'); 
        output_type = input(prompt_output); 
    end 
end 
  
%% Load in data files 
  









% CRISPR - original files which contain raw data - i.e. 








% RENAMED files (to convert from DAVID gene (numeric) IDs 








%clear some variables from workspace 
clear p*; clear crisp_1; clear crisp_2; clear david_1;  
clear david_2; clear rename_1; clear rename_2;  
  




% this performs the entire comparison and prioritization  
% order matters: david_file_1, rename_file_1, david_file_2, 
rename_file_2, 








%% write to excel file 
%ask user for output file name 
prompt_file = 'Name the output file (do not reuse names): 
\n'; 
output_name = input(prompt_file,'s'); 
output_name = [output_name,'.xls']; 
  







7.2 Function: pathwaycomp.m 
function [storer] = 
pathwaycomp(inputArg1,checker1,inputArg2,checker2,fdrthresh
old1,originalList1,originalList2,fdrthreshold2,value) 
%PATHWAYCOMP: This function is the primary tool in 
performing pathway 
%analysis. The user parses several input arguments to 
automatically compare 
%multiple genetic pathway analyses. The function 
prioritizes the results according to 
%the FDR-values of the genetic pathways, and the individual 
genes in those 
%pathways. To operate correctly, and provide an effective 
output, the functions reversename.m, changed_list_comp.m, 
%and printer.m are utilized. 
%  % Input Arguments:  
   %    - inputArg1: a table containing the pathway 




   %    - inputArg2: a table containing the pathway 
analysis from DAVID 
   %    - checker1: a table containing the renamed gene 
IDs, used for 
   %    conversation between number IDs and name IDs 
   %    - checker2: a table containing the renamed gene 
IDs, used for 
   %    conversation between number IDs and name IDs 
   %    - fdrthreshold1: a value between 0 and 1 to ensure 
pathway fdr 
   %    value is significant 
   %    - originalList1: a table containing the CRISPR 
screen data (gene 
   %    list) 
   %    - originalList2: a table containing the CRISPR 
screen data (gene 
   %    list) 
   %    - fdrthreshold2: a value between 0 and 1 to ensure 
gene fdr value 
   %    is significant 
   %    - value: output format (value of 0 or 1 - binary) 
   %  
   % Output:  
   %    - storer: a table containing the name of 
overlapping Pathways, FDR 
   %    values of Pathways, Overlapping Genes from List 
1/List 2, FDR 
   %    values of Gene List 1/ Gene List 2 
  
%% Pathwaycomp Function  
  
%isolate the pathways from the loaded table & compare them 
term1 = inputArg1.Term;  
term2 = inputArg2.Term; 
  
%isolate the FDR-values and compare against threshold 
(comparison happens later) 
fdr1 = inputArg1.FDR; 
fdr2 = inputArg2.FDR; 
  
%isolate the gene IDs - this actually gives you a string, 
not gene numbers! 
gene1 = inputArg1.Genes;  





%convert the string gene IDs into numeric gene IDs 
for g = 1:length(gene1) 
    holder = str2num(gene1{g}(gene1{g}~= ' ')); 
    gene1{g} = holder'; 
end 
for g = 1:length(gene2) 
    holder = str2num(gene2{g}(gene2{g}~= ' ')); 




ind = 1; 
  
%the for-loop to perform checking 
for i = 1:length(term1) 
    s1 = string(term1(i)); %assign ONE gene-pathway from 
list ONE to a variable 
    if(s1 == '') %this is the blank space checker - 
prevents forever looping 
        break; 
    end 
    for j = 1:length(term2) 
        s2 = string(term2(j)); %assign ONE gene-pathway 
from list TWO to a variable 
        if(s2 == '') %this is the blank space checker - 
prevents forever looping 
            break; 
        end 
        if((s1 == s2) && (fdr1(i) <= fdrthreshold1) && 
(fdr2(j) <= fdrthreshold1)) %the comparison point of 
pathways & fdr value 
            %extended version 
            temp_store{ind,1} = term1(i); %store the term 
(gene pathway) 
            temp_store{ind,2} = fdr1(i); %store the fdr-
value from list 1 
            temp_store{ind,3} = fdr2(j); %store the fdr-
value from list 2 
            temp_store_gene{ind,1} = gene1{i}; %temporary 





            temp_store_gene{ind,2} = gene2{j}; %temporary 
storage for gene from overlapped pathways - this is for 
list 2 
             
            %non-extended Version 
            temp_store_nonExtended{ind,1} = term1(i); 
%store the term (gene pathway) 
            temp_store_nonExtended{ind,2} = fdr1(i); %store 
the fdr-value from list 1 
            temp_store_nonExtended{ind,3} = fdr2(j); %store 
the fdr-value from list 2 
             
            ind = 1 + ind; %increment the counting variable 
        end 
    end 
end 
  
clear ind; %clear the independent counting variable 
  
%reversename function 
% - inputs: 
%           temp_store [variable that contains common 
pathways] 
%           checker1 [renamed gene IDs for list 1] 
%           checker2 [renamed gene IDs for list 2] 
% - outputs:  
%           cell variable that is well-organized and shows 
prioritized results 
  





% - inputs: 
%           changed_name [output from reversename function] 
%           originalList1 [CRISPR gene list for list 1] 
%           originalList2 [CRISPR gene list for list 2] 
%           fdrthreshold2 [fdr-thresholding value for 
CRISPR gene lists] 
% - outputs:  
%           cell variable that is well-organized and shows 
thresholded, and 










%add the named gene lists to temp_store  
for i = 1:length(temp_store) 
   %extended version 
   temp_store{i,4} = result{i,1}; %gene list 1 
   temp_store{i,5} = result{i,3}; %fdr list 1 
   temp_store{i,6} = result{i,2}; %gene list 2 
   temp_store{i,7} = result{i,4}; %fdr list 2 
    
   %non-extended version 
   temp_store_nonExtended{i,4} = result{i,1}; 




% - inputs: 
%           result [output from changed_list_comp function] 
%   NOTE: column 1 & 3 are related, 2 & 4 are related. 
Column 1, 2 are Gene 
%   IDs, Column 3, 4 are fdr-values of Genes from Column 1, 
2 respectively. 
% - outputs: 
%           cell-variable that is well-organized and 
prioritized - ready to 
%           be printed to Excel.  
  
%print results in a NEAT format - default formats are not 
appropriate 
output = printer(temp_store); 
  
%determine output format type 
if(value == 1) %extended  
    %returns a table with pathways, fdr of pathways, gene 
ID names, fdr of gene lists 
    storer = cell2table(output,'VariableNames',{'Term' 'FDR 
w/ Condition 1' 'FDR w/ Condition 2' 'Gene List 1' 'FDR of 
Gene List 1' 'Gene List 2' 'FDR of Gene List 2'}); 




    %returns a table with pathways, fdr of pathways, and 
gene ID names 
    storer = 
cell2table(temp_store_nonExtended,'VariableNames',{'Term' 
'FDR w/ Condition 1' 'FDR w/ Condition 2' 'Gene List 1' 
'Gene List 2'}); 
end 
     
end %end of function file 
 
7.3 Function: reversename.m 
function [result] = reversename(temp,inputArg1,inputArg2) 
%REVERSENAME: This function can convert the number IDs to 
the name IDs. 
%This is especially useful after the comparison of multiple 
pathways yields 
%a cell array that has number IDs. %This conversion is 
critical as the 
%output of this function is the input of the 
changed_list_comp.m function. 
%  % Input Arguments:  
   %    - temp: a cell array containing the common pathways 
& common genes 
   %    on those pathways 
   %    - inputArg1: a table containing the renamed gene 
IDs, used for 
   %    conversation between number IDs and name IDs 
   %    - inputArg2: a table containing the renamed gene 
IDs, used for 
   %    conversation between number IDs and name IDs 
   % 
   % Output:  
   %    - result: cell array that converts number IDs to 
name IDs. Also 
   %    organizes results in ascending order 
(prioritization technique) 
  
%isolate the individual gene number IDs from pathwaycomp 
%isolate the 'TO' and 'FROM' column from DAVID renamed gene 
IDs 
to1 = inputArg1.To; 
to2 = inputArg2.To; 




from2 = inputArg2.From; 
  
%create the string array 




for i = 1:length(temp) 
    storage1 = strings; %initialize the string array 
    ind = 1; %independent counter variable 
    storage1(ind) = "Number ID is not available"; %failsafe 
result 
    for j = 1:length(temp{i,1}) 
        s1 = temp{i,1}(j); 
        for k = 1:length(to1) 
            s2 = to1(k); 
            if(s2 == s1) %this comparison checks if the 
numbers from DAVID match - i.e. checks if gene IDs match 
                storage1(ind) = from1(k); %store result if 
match 
                ind = ind + 1; 
                break; %this 'break' optimizes the code. 
The comparison will only be 'TRUE' once, after finding it, 
exit the if-statement. 
            end 
        end 
    end 
    result{i,1} = storage1'; 
    clear storage1; %clears the variable to start storing 
comparison results 
end %end for-loop of list1 comparison 
  
%list 2 comparison 
for i = 1:length(temp) 
    storage1 = strings; %initialize the string array 
    ind = 1; %independent counter variable 
    storage1(ind) = "Number ID is not available"; %failsafe 
result 
    for j = 1:length(temp{i,2}) 
        s1 = temp{i,2}(j); 
        for k = 1:length(to2) 
            s2 = to2(k); 
            if(s2 == s1) %this comparison checks if the 




                storage1(ind) = from2(k); %store result if 
match 
                ind = ind + 1; 
                break; %this 'break' optimizes the code. 
The comparison will only be 'TRUE' once, after finding it, 
exit the if-statement. 
            end 
        end 
    end 
    result{i,2} = storage1'; 
    clear storage1; %clears the variable to start storing 
comparison results 
end %end for-loop of list2 comparison 
  
end %end of function file 
 
7.4 Function: changed_list_comp.m 
function [result] = 
changed_list_comp(geneNames,inputArg1,inputArg2,fdr_thresho
ld) 
%CHANGED_LIST_COMP: This function thresholds the gene lists 
to the 
%user-specified value. Additionally, it prioritizes the 
results in an 
%ascending FDR-value format (current prioritization 
technique) and creates 
%the cell array output which will be the input for the 
printer.m function.  
%  % Input Arguments:  
   %    - geneNames: a table - this is the output from 
reversename function 
   %    - inputArg1: a table containing the CRISPR screen 
data (gene 
   %    list) 
   %    - inputArg2: a table containing the CRISPR screen 
data (gene 
   %    list) 
   %    - fdrthreshold: fdr-thresholding value for CRISPR 
gene lists 
   %  




   %    - result: cell array that thresholds the gene 
lists, and 
   %    prioritizes the output in ascending order (current 
prioritization 
   %    technique) 
    
%isolate the string from the loaded table 
test1 = inputArg1.target;  
test2 = inputArg2.target; 
  
%isolate the fdr values into an array 
fdr1 = inputArg1.fdr; 
fdr2 = inputArg2.fdr; 
  
%comparison 
%gene list 1 comparison 
for i = 1:length(geneNames) 
    storage1 = strings; %initialize the string array 
    ind = 1; %independent counter variable 
    storage1(ind) = "No CRISPR screened Genes available at 
this threshold"; 
    fdr_organizer(ind) = 100; %initialize an fdr storage 
array 
    for j = 1:length(geneNames{i,1}) 
        s1 = geneNames{i,1}(j); 
        for k = 1:length(test1) 
            s2 = test1(k); 
            if(strcmp(s1,s2) && (fdr1(k) <= fdr_threshold)) 
%this comparison checks if the numbers from DAVID match - 
i.e. checks if gene IDs match 
                storage1(ind) = test1(k); %if there is a 
similarity (that meets the threshold), store in storage1 
                fdr_organizer(ind) = fdr1(k); %store the 
fdr of the gene that meets the threshold + similarity 
condition 
                ind = ind + 1; %increment independent 
counter 
                break; %this 'break' optimizes the code. 
The comparison will only be 'TRUE' once, after finding it, 
exit the if-statement. 
            end 
            if(strcmp(s2,'')) %this is the blank space 
checker for inputArg1 and inputArg2 - they have too many 




                break; 
            end 
        end 
    end 
     
    %organize the gene list in order of descending fdr 
values 
    descender = table(storage1',fdr_organizer'); 
    holder = sortrows(descender,{'Var2'},{'ascend'}); 
     
    result{i,1} = strjoin(holder.Var1,', '); %converts the 
cell array into a string variable 
    result{i,3} = num2str(sort(fdr_organizer)); %organizes 
the fdr-values in ascending order (like the genes) and 
makes it into a string 
    clear storage1; %clears the variable to start storing 
comparison results 
    clear fdr_organizer; %clears the variable to start 
storing comparison results 
  
end %end for-loop of list 1 comparison 
  
%gene list 2 comparison 
for i = 1:length(geneNames) 
    storage1 = strings; %initialize the string array 
    ind = 1; %independent counter variable 
    storage1(ind) = "No CRISPR screened Genes available at 
this threshold"; 
    fdr_organizer(ind) = 100; %initialize an fdr array 
    for j = 1:length(geneNames{i,1}) 
        s1 = geneNames{i,1}(j); 
        for k = 1:length(test2) 
            s2 = test2(k); 
            if(strcmp(s1,s2) && (fdr2(k) <= fdr_threshold)) 
%this comparison checks if the numbers from DAVID match - 
i.e. checks if gene IDs match 
                storage1(ind) = test2(k); %if there is a 
similarity (that meets the threshold), store in storage1 
                fdr_organizer(ind) = fdr2(k); %store the 
fdr of the gene that meets the threshold + similarity 
condition 





                break; %this 'break' optimizes the code. 
The comparison will only be 'TRUE' once, after finding it, 
exit the if-statement. 
            end 
            if(strcmp(s2,'')) %this is the blank space 
checker for inputArg1 and inputArg2 - they have too many 
blank spaces at the end 
                break; 
            end 
        end 
    end 
     
    %organize the gene list in order of descending fdr 
values 
    descender = table(storage1',fdr_organizer'); 
    holder = sortrows(descender,{'Var2'},{'ascend'}); 
     
    result{i,2} = strjoin(holder.Var1,', '); %converts the 
cell array into a string variable 
    result{i,4} = num2str(sort(fdr_organizer)); %organizes 
the fdr-values in ascending order (like the genes) and 
makes it into a string 
    clear storage2; %clears the variable to start storing 
comparison results 
    clear fdr_organizer; %clears the variable to start 
storing comparison results 
     
end %end for-loop of list 2 comparison 
  
end %end of function file 
 
7.5 Function: printer.m 
function [temp] = printer(temp_store) 
%PRINTER: This function allows for the clean formatting of 
the 
%extended-format Excel spreadsheet.  
%   % Input Arguments: 
    %    - temp_store: output from changed_list_comp 
function] 
%   NOTE: column 1 & 3 are related, 2 & 4 are related. 
Column 1, 2 are Gene 






    % Output Arguments: 
    %    - temp: cell-variable that is well-organized and 
shows prioritized 
    %    results to readily print to Excel. 
%    
  
[z, zz] = size(temp_store); %counter-limit from inArg1 
b = 1; %row-counter for temp variable (list 1) 
h = 1; %row-counter for temp variable (list 2) 
  
%eventually, the two row-counters will compare against each 
other and the 
%larger number will prevail to ensure continuity in 
printing 
  
for a = 1:z %first for-loop to parse through the original 
argument 
     
    b_keeper = b; %creates a clone of b; 
    h_keeper = h; %creates a clone of h; 
     
    temp{b,1} = temp_store{a,1}; %this stores the pathway 
term 
    temp{b,2} = temp_store{a,2}; %this stores the fdr value 
with condition 1 
    temp{b,3} = temp_store{a,3}; %this stores the fdr value 
with condition 2 
     
    %isolating the string of genes 
    temp_holder_string = temp_store{a,4};  
    holder_string = 
textscan(temp_holder_string,'%s','Delimiter',','); 
%changing string of genes back into a cell array 
     
    temp_holder_numeric = temp_store{a,5}; 
    holder_numeric = str2num(temp_holder_numeric);  
     
    for i = 1:length(holder_string) 
        for j = 1:length(holder_string{i,1}) %accessing the 
specific area where the genes are 
            temp{b,4} = holder_string{i,1}(j); 
            b = b+1; %increment the value of b             




    end 
     
    for i = 1:length(holder_numeric) 
        temp{b_keeper,5} = holder_numeric(i); 
        b_keeper = b_keeper + 1; %this ensures we start at 
the same place as 'b' 
    end 
     
    clear temp_holder_string; clear temp_holder_numeric;  
    clear holder_string; clear holder_numeric; 
     
    %isolating the string of genes 
    temp_holder_string = temp_store{a,6};  
    holder_string = 
textscan(temp_holder_string,'%s','Delimiter',','); 
%changing string of genes back into a cell array 
     
    temp_holder_numeric = temp_store{a,7}; 
    holder_numeric = str2num(temp_holder_numeric);  
     
    for i = 1:length(holder_string) 
        for j = 1:length(holder_string{i,1}) %accessing the 
specific area where the genes are 
            temp{h,6} = holder_string{i,1}(j); 
            h = h+1; %increment the value of b             
        end 
    end 
     
    for i = 1:length(holder_numeric) 
        temp{h_keeper,7} = holder_numeric(i); 
        h_keeper = h_keeper + 1; %this ensures we start at 
the same place as 'h' 
    end 
     
    if(b > h) %this logical statement ensures the data is 
correctly copied 
        h = b; 
    else %i.e. h > b 
        b = h; 
    end     
     
    clear temp_holder_string; clear temp_holder_numeric;  





end %end of function file 
 
 
